Req. No. 2408 Page 1 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
STATE OF OKLAHOMA
2nd Session of the 58th Legislature (2022)
SENATE BILL 1151 By: Standridge
AS INTRODUCED
An Act relating to the Anti-Drug Diversion Act;
amending 63 O.S. 2021, Sections 2-309B and 2-309D,
which relate to definitions and central repository
information; modifying definition; allowing certain
disclosure; and providing an effective date.
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTION 1. AMENDATORY 63 O.S. 2021, Section 2 -309B, is
amended to read as follows:
Section 2-309B. For the purposes of the Anti -Drug Diversion
Act:
1. "Bureau" means the Oklahoma State Bur eau of Narcotics and
Dangerous Drugs Control;
2. "Dispenser" means a person who distributes a Schedule II
controlled dangerous substance, but does not include a licensed
hospital pharmacy or a licensed nurse or medication aide who
administers such a subst ance at the direction of a licensed
physician;
Req. No. 2408 Page 2 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
3. "Dispenser's registration number" means the dispenser's
Oklahoma State Bureau of Narcotics and Dangerous Drugs Control
registration number or, in the case of a pharmacist, the National
Association of Board s of Pharmacy number for the pharmacy where the
dispensation is made;
4. "Exception report" means an output of da ta indicating
Schedule II controlled dangerous substance dispensation which is
outside expected norms for a prescriber practicing a particular
specialty or field of health care, for a dispenser doing busine ss in
a particular location, or for a recipient;
5. "Recipient" means the person for whom a prescription is
prescribed and who is the lawful intended ultimate user;
6. "Recipient's agent" means a person who is authorized by the
ultimate user to pick up t he recipient's medication and deliver it
to the recipient or a person who c laims a prescription other than
the person to whom the medication is prescribed;
7. "Recipient's identification numb er" and "recipient's agent's
identification number " means the unique number contained on a valid
passport, military identification card, dr iver license, or
identification card issued to a recipient pursuant to Section 6 -105
of Title 47 of the Oklahoma Sta tutes or similar statute of another
state if the recipient is no t a resident of the State of Oklahoma,
or, if the recipient is less than ei ghteen (18) years old and has no
such identification, the unique number contained on a valid
Req. No. 2408 Page 3 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
passport, military ident ification card, driver license, or
identification card issued to the recipient's parent or guardian
pursuant to Section 6-105 of Title 47 of the Oklahoma Statutes or
similar statute of another state if the parent or guardian is not a
resident of the State of Oklahoma, or, if the controlled dangerous
substance is obtained for an animal, the unique number contained on
the animal owner's valid driver license or identification card
issued pursuant to Section 6 -105 of Title 47 of the Oklahoma
Statutes or similar statute of another state if the owner is not a
resident of the State of Oklahoma. Nonresident drug outlets
registered pursuant to the O klahoma Pharmacy Act and resident drug
outlets defined in Section 353.1 of Title 59 of the Oklahoma
Statutes are exempt from the picture identification requirement if
the nonresident and resident drug outlets have obtained the
identification of the patient through the prescription benefit plan
of the patient forms of identification listed in 8 CFR
274a.2(b)(1)(v)(A) and (B);
8. "Registrant" means a person, persons, corporation or ot her
entity who has been issued by the Director of the Oklahoma State
Bureau of Narcotics and Dangerous Drugs Control a registration
pursuant to Section 2-302 of this title; and
9. "State" means any state, territory, or possession of the
United States, the District of Columbia, or foreign nation.
Req. No. 2408 Page 4 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
SECTION 2. AMENDATORY 63 O.S. 2021, Section 2 -309D, is
amended to read as follows:
Section 2-309D. A. The information collected at the central
repository pursuant to the Anti -Drug Diversion Act shall be
confidential and shall not be ope n to the public. Access to the
information shall be limited to:
1. Peace officers certified pursuant to Section 3311 of Title
70 of the Oklahoma Statutes who are employed as investigative agents
of the Oklahoma State Bureau of Narcotics and Dangerous Dru gs
Control;
2. The United State s Drug Enforcement Administ ration Diversion
Group Supervisor;
3. The executive director or chief investigator, as designated
by each board, of the following state boards:
a. Oklahoma State Board of Podiatric Medical Examine rs,
b. Oklahoma Board of Dentistry,
c. State Board of Pharmacy,
d. State Board of Medical Licensure and Supervision,
e. State Board of Osteopathic Examiners,
f. State Board of Veterinary Medical Examiners,
g. Oklahoma Health Care Authority,
h. Department of Mental Health and Substance Abuse
Services,
i. Board of Examiners in Optometry,
Req. No. 2408 Page 5 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
j. Oklahoma Board of Nursing,
k. Office of the Chief Medical Examiner, and
l. State Board of Health;
4. A multicounty grand jury properly convened pursuant to the
Multicounty Grand Jury Act;
5. Medical practiti oners employed by the Unite d States
Department of Veterans Affairs, the United States Military, or other
federal agencies treating patients in this state;
6. At the discretion of the Director of the O klahoma State
Bureau of Narcotics and Dangerous Dru gs Control, medical
practitioners and their staff, including those employed by the
federal government in this state ; and
7. The members of the Opioid Overdose Fatality Rev iew Board for
the purpose of carrying out the duties prescribed by Section 2 -1001
of this title.
B. This section shall not prevent access, at the discretion of
the Director of the Oklahoma State Bureau of Narcotics and Dangerous
Drugs Control, to investig ative information by peace office rs and
investigative agents of federal, state, trib al, county or municipal
law enforcement agencies, district attorneys and the Attorney
General in furtherance of criminal, civil or administrative
investigations or prosecut ions within their respective
jurisdictions, designated legal, communications, and an alytical
employees of the Burea u, and to registrants in furtherance of
Req. No. 2408 Page 6 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
efforts to guard against the diversion of controlled dangerous
substances.
C. This section shall not prevent the disclosure, at the
discretion of the Director of the Oklahoma State Bur eau of Narcotics
and Dangerous Drugs Control, of statistical information gathered
from the central repository to the general public which shall be
limited to types and quan tities of controlled substances d ispensed
and the county where dispensed for statistical, rese arch, substance
abuse prevention, or educational purposes, provided that cons umer
confidentiality is not comprom ised.
D. This section shall not prevent the discl osure, at the
discretion of the Director of the Oklahoma State Bureau of Narcotics
and Dangerous Drugs Control, of prescription-monitoring-program
information to prescription -monitoring programs of other states
provided a reciprocal data-sharing agreement is in place.
E. The Department o f Mental Health and Substance Abuse Services
and the State Department of Health ma y utilize the information in
the central repository for statistical, research, substance abuse
prevention, or educational purposes, provided that consumer
confidentiality is not compromised.
F. Any unauthorized disclosure of any information collected at
the central repository provided by the Anti -Drug Diversion Act shall
be a misdemeanor. Violation of the pro visions of this section shall
Req. No. 2408 Page 7 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
be deemed willful neglect of duty and shall be grounds for removal
from office.
G. 1. Registrants shall have access t o the central repository
for the purposes of patient treatment and to aid in the
determination in presc ribing or screening new patient s. The
physician or designee shall prov ide, upon request by the patient,
the history of the patient or the query histor y of the patient.
2. a. Prior to prescribing or authorizing for refill, if one
hundred eighty (180) days have elapse d prior to the
previous access and check, of opiates, synthe tic
opiates, semisynthetic opiates, benzodiazepin e or
carisoprodol to a patient of record, registrants or
members of their medical or administrative staff shall
be required to access the informati on in the central
repository to assess medical necessity and the
possibility that the patient may be unlawful ly
obtaining prescription drug s in violation of the
Uniform Controlled Dangerous Substances Act. The duty
to access and check shall not alter or o therwise amend
appropriate medical standards of care. The r egistrant
or medical provider shall note in the p atient file
that the central repository has been checked and may
maintain a copy of the information.
Req. No. 2408 Page 8 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
b. The requirements set forth in subparagraph a of this
paragraph shall not apply:
(1) to medical practitioners who prescribe the
controlled substances set forth in subparagraph a
of this paragraph for hospice or end -of-life
care, or
(2) for a prescription of a controlled substance set
forth in subparagraph a of this paragraph that is
issued by a practitioner for a patient residing
in a nursing facility as d efined by Section 1-
1902 of this title, provided that the
prescription is issued to a resident of such
facility.
3. Registrants shall not be liabl e to any person for any cla im
of damages as a result of acce ssing or failing to access the
information in the central repository and no lawsuit may be
predicated thereon.
4. The failure of a registrant to access and check the central
repository as require d under state or federal la w or regulation may,
after investigation, be grounds for the licensing board of th e
registrant to take disc iplinary action against the registrant.
H. The Oklahoma State Board of Podiatric Medical Examiners, the
State Oklahoma Board of Dentistry, the State Board of Medical
Licensure and Supervision, the State Board of Examiners in
Req. No. 2408 Page 9 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
Optometry, the State Oklahoma Board of Nursing, the Stat e Board of
Osteopathic Examiners and the State Board of Veterinary Medical
Examiners shall have the sole responsibility for enforcement of the
provisions of subsection G of this section. Nothing in this section
shall be construed s o as to permit the Direc tor of the State Bureau
of Narcotics and Dangerous Drugs Control to assess administrative
fines provided for in Section 2 -304 of this title.
I. The Director of the Oklahoma State Bureau of Narcotics and
Dangerous Drugs Control, or a designee thereof, sha ll provide a
monthly list to the Directors of the Oklahoma State Board of
Podiatric Medical Examiners, the State Oklahoma Board of Dentistry,
the State Board of Medical L icensure and Supervision, the State
Board of Examiners in Optometry, the State Oklahoma Board of
Nursing, the State Board of Osteopathic Examiners and the State
Board of Veterinary Medical Examiners of the top twenty prescribers
of controlled dangerous substan ces within their respective areas of
jurisdiction. Upon discovering that a registrant is prescribing
outside the limitations of his or her licensure or outside of drug
registration rules or applicable stat e laws, the respective
licensing board shall be no tified by the Bureau in writing. Suc h
notifications may be considered complaints for the purpose of
investigations or other actions by the respective licensing board.
Licensing boards shall have exclusive jurisdiction to take actio n
against a licensee fo r a violation of subsection G of this section.
Req. No. 2408 Page 10 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
J. Information regarding fatal and non fatal overdoses, other
than statistical information as required by Section 2 -106 of this
title, shall be completely conf idential. Access to this i nformation
shall be strictly limited to the Director of the Oklahoma State
Bureau of Narcotics and Dangerous Drugs Control or desig nee, the
Chief Medical Examiner, state agencies and boards provided in
subsection A of this sectio n, and the registrant that enters the
information. Registrants shall not be liable to any person for a
claim of damages for information reported pursuant to the provisions
of Section 2-105 of this title.
K. The Director of the Oklahoma State Bureau of Na rcotics and
Dangerous Drugs Control shall provide adequate means and procedures
allowing access to central repository information for re gistrants
lacking direct computer access.
L. Upon completion of an investigation in which it is
determined that a death was caused by an overdose, either
intentionally or unintentionally, of a controlled da ngerous
substance, the medical examiner shall be required to report t he
decedent's name and date of birth to the Oklahoma State Bureau of
Narcotics and Dangerous Drugs C ontrol. The Oklahoma State Bureau of
Narcotics and Dangerous Drugs Control shall be re quired to maintain
a database containing the clas sification of medica l practitioners
who prescribed or authorized controlled dangerous substances
pursuant to this subsec tion.
Req. No. 2408 Page 11 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
M. The Oklahoma Stat e Bureau of Narcotics a nd Dangerous Drugs
Control is authorized to provide unsolicited notification to the
licensing board of a pharmacist or practitioner if a patient has
received one or more prescriptions for controlled substan ces in
quantities or with a frequency inconsistent with generally
recognized standards of safe practice. An unsolicited notification
to the licensing board of the pract itioner pursuant to this section:
1. Is confidential;
2. May not disclose information that is confidential pursu ant
to this section; and
3. May be in a summary form suffic ient to provide notice of the
basis for the unsolicited notification.
SECTION 3. This act shall become effective November 1, 2022.
58-2-2408 BG 12/30/2021 9:01:23 AM